Patterns and predictors of remission, response and recovery in major depression treated with fluoxetine or nortriptyline

References

• Kiloh L G, Andrews G, Neilson M. The long-term outcome of depressive illness. British Journal of Psychiatry 1988; 153: 752–757
   PubMed Web of Science ®Google Scholar
• Keller M B, Klerman G L, Lavori P W, Coryell W, Endicott J, Taylor J. Long-term outcome of episodes of major depression. Journal of American Medical Association 1984; 252: 788–792
   PubMed Web of Science ®Google Scholar
• Prien R F, Carpenter L L, Kupfer D J. The definition and operational criteria for treatment outcome of major depressive disorder: a review of the current research literature. Archives of General Psychiatry 1991; 48: 796–800
   PubMed Web of Science ®Google Scholar
• Frank E, Prien R F, Jarrett R B, et al. Conceptualization and rationale for consensus definitions of terms in major depressive disorder: remission, recovery, relapse, and recurrence. Archives of General Psychiatry 1991; 48: 851–855
   PubMed Web of Science ®Google Scholar
• Sullivan P F, Joyce P R. Effects of exclusion criteria in depression treatment studies. Journal of Affective Disorders 1994; 32: 21–26
   PubMedGoogle Scholar
• Sullivan P F, Wells J E, Joyce P R, Bushnell J A, Mulder R T, Oakley-Browne M A. Family history of depression in clinic and community samples. Journal of Affective Disorders 1996; 40: 159–168
   PubMed Web of Science ®Google Scholar
• Joyce P R, Paykel E S. Predictors of drug response in depression. Archives of General Psychiatry 1989; 46: 89–99
   PubMed Web of Science ®Google Scholar
• Joyce P R, Mulder R T, Cloninger C R. Temperament predicts clomipramine and desipramine response in major depression. Journal of Affective Disorders 1994; 30: 35–46
   PubMed Web of Science ®Google Scholar
• Sullivan P F, Wilson D A, Mulder R T, Joyce P R. The hypothalamic-pituitary-thyroid axis in major depression. Acta Psychiatrica Scandinavica 1997; 95: 370–378
   Google Scholar
• Spitzer R L, Williams J B, Gibbon M, First M B. The structured clinical interview for DSM-III-R (SCID): I. history, rationale, and description. Archives of General Psychiatry 1992; 49: 624–629
   PubMed Web of Science ®Google Scholar
• Montgomery S A, Asberg M A. A new depression scale designed to be sensitive to change. British Journal of Psychiatry 1979; 134: 382–389
   PubMed Web of Science ®Google Scholar
• Hamilton M. A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry 1960; 23: 56–62
   PubMed Web of Science ®Google Scholar
• Parker G, Hadzi-Pavlovic D, Wilhelm K, et al. Defining melancholia: properties of a refined sign-based measure. British Journal of Psychiatry 1994; 164: 316–326
   PubMed Web of Science ®Google Scholar
• Derogatis L. SCL-90-R administration, scoring and procedures manual. Clinical Psychometric Research, Baltimore, MD 1983
   Google Scholar
• Weissman M M, Bothwell S. Assessment of social adjustment by patient self-report. Archives of General Psychiatry 1976; 33: 1111–1115
   PubMed Web of Science ®Google Scholar
• Cloninger C R, Svrakic D M, Przybeck T R. A psychobiological model of temperament and character. Archives of General Psychiatry 1993; 50: 975–990
   PubMed Web of Science ®Google Scholar
• Parker G. The parental bonding instrument: psychometric properties reviewed. Psychiatric Developments 1989; 4: 317–335
   Google Scholar
• Weissman A N, Beck A T. Development and validation of the dysfunctional attitudes scale: a preliminary investigation. paper presented at the meeting of the American Educational Research Association T, Canada, 1978 edition
   Google Scholar
• Boyce P, Parker G. Development of a scale to measure interpersonal sensitivity. Australian and New Zealand Journal of Psychiatry 1989; 23: 341–351
   PubMed Web of Science ®Google Scholar
• Kornstein S G, Schatzberg A F, Thase M E, et al. Gender differences in treatment response to sertraline versus imipramine in chronic depression. American Journal of Psychiatry 2000; 157: 1445–1452
   PubMed Web of Science ®Google Scholar
• Steffens D C, Krishnan K R, Helms M J. Are SSRIs better than TCAs? Comparison of SSRIs and TCAs: a meta-analysis. Depression and Anxiety 1997; 6: 10–18
   PubMedGoogle Scholar
• Simon G E, VonKorff M, Heiligenstein J H, et al. Initial antidepressant choice in primary care: effectiveness and cost of fluoxetine versus tricyclic antidepressants. Journal of the American Medical Association 1996; 275: 1897–1902
   PubMed Web of Science ®Google Scholar
• Croghan T W, Lair T J, Engelhart L, et al. Effect of antidepressant therapy on health care utilization and costs in primary care. Psychiatric Services 1997; 48: 1420–1426
   PubMedGoogle Scholar
• Katon W, von Korff M, Lin E, Bush T, Ormel J. Adequacy and duration of antidepressant treatment in primary care. Medical Care 1992; 30: 67–76
   PubMed Web of Science ®Google Scholar
• Khan A, Dager S R, Cohen S, Avery D H, Scherzo B, Dunner D L. Chronicity of depressive episode in relation to antidepressantplacebo response. Neuropsychopharmacology 1991; 4: 125–130
   PubMed Web of Science ®Google Scholar
• Lam R W, Stewart J N. The validity of atypical depression in DSM-IV. Comprehensive Psychiatry 1996; 37: 375–383
   Google Scholar
• McGrath P J, Stewart J W, Harrison W M, et al. Predictive value of symptoms of atypical depression for differential drug treatment outcome. Journal of Clinical Psychopharmacology 1992; 12: 197–202
   PubMed Web of Science ®Google Scholar
• Stewart J W, McGrath P J, Quitkin F M, et al. Relevance of DSM-III depressive subtype and chronicity of antidepressant efficacy in atypical depression: differential response to phenelzine, imipramine, and placebo. Archives of General Psychiatry 1989; 46: 1080–1087
   Google Scholar
• Pande A C, Birkett M, Fechner-Bates S, Haskett R F, Greden J F. Fluoxetine versus phenelzine in atypical depression. Biological Psychiatry 1996; 40: 1017–1020
   PubMed Web of Science ®Google Scholar
• Mulder R T, Watkins W GA, Joyce P R, Luty S E. Serotonergic antidepressants are superior to noradrenergic antidepressants in depressed young adults. Acta Psychiatrica Scandinavica 2002, (in press)
   Google Scholar
• Emslie G J, Rush A J, Weinberg W A, et al. A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression. Archives of General Psychiatry 1997; 54: 1031–1037
   PubMed Web of Science ®Google Scholar
• Parker G, Mitchell P, Wilhelm K, et al. Are the newer antidepressant drugs as effective as established physical treatments? Results from an Australasian clinical panel review. Australian and New Zealand Journal of Psychiatry 1999; 33: 874–881
   PubMed Web of Science ®Google Scholar
• Roose S P, Glassman A H, Attia E, Woodring S. Comparative efficacy of selective serotonin reuptake inhibitors and tricyclics in the treatment of melancholia. American Journal of Psychiatry 1994; 151: 1735–1739
   PubMed Web of Science ®Google Scholar
• Wells K B. Treatment research at the crossroads: the scientific interface of clinical trials and effectiveness research. American Journal of Psychiatry 1999; 156: 5–10
   PubMed Web of Science ®Google Scholar